Free Trial

Biomea Fusion Q3 2024 Earnings Report

Biomea Fusion logo
$4.23 +0.15 (+3.68%)
(As of 12/20/2024 05:31 PM ET)

Biomea Fusion Earnings Headlines

Brokerages Set Biomea Fusion, Inc. (NASDAQ:BMEA) PT at $39.36
Barclays Remains a Hold on Biomea Fusion (BMEA)
Buy this coin BEFORE Inauguration Day …
Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.
Biomea Fusion (BMEA) Receives a Buy from Truist Financial
What's Driving Biomea Fusion? Stock Soars 25%
See More Biomea Fusion Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biomea Fusion? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biomea Fusion and other key companies, straight to your email.

About Biomea Fusion

Biomea Fusion (NASDAQ:BMEA), a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.

View Biomea Fusion Profile

More Earnings Resources from MarketBeat

Upcoming Earnings